Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Sylatron
DRUG
2 trials
Sponsors
H. Lee Moffitt Cancer Center and Research Institute
, Aiwu Ruth He, MD
Conditions
Advanced Cholangiocarcinoma
Melanoma
Phase 1
Yervoy With Sylatron Unresectable Stage 3 or 4 Melanoma
Completed
NCT01496807
H. Lee Moffitt Cancer Center and Research Institute
Melanoma
Start: 2012-02-17
End: 2016-08-29
Updated: 2017-04-28
Phase 2
Evaluating Combination Immunotherapy for Advanced Cholangiocarcinoma With Pembrolizumab and PEG-Intron
Terminated
NCT02982720
Aiwu Ruth He, MD
Advanced Cholangiocarcinoma
Start: 2017-07-05
End: 2018-02-09
Updated: 2022-02-16
Related Papers
A phase IB study of ipilimumab with peginterferon alfa-2b in patients with unresectable melanoma
Journal for ImmunoTherapy of Cancer
2016-11-21
25 citations
A phase IB study of ipilimumab with peginterferon alfa-2b for patients with unresectable stages IIIB/C/IV melanoma.
Journal of Clinical Oncology
2014-05-20
11 citations